AU3344299A - Th2-migration promoters containing w/o emulsions - Google Patents

Th2-migration promoters containing w/o emulsions

Info

Publication number
AU3344299A
AU3344299A AU33442/99A AU3344299A AU3344299A AU 3344299 A AU3344299 A AU 3344299A AU 33442/99 A AU33442/99 A AU 33442/99A AU 3344299 A AU3344299 A AU 3344299A AU 3344299 A AU3344299 A AU 3344299A
Authority
AU
Australia
Prior art keywords
emulsions
promoters containing
migration promoters
migration
promoters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33442/99A
Inventor
Kazutoshi Horie
Kazuyoshi Masuda
Ryuji Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU3344299A publication Critical patent/AU3344299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU33442/99A 1998-04-20 1999-04-15 Th2-migration promoters containing w/o emulsions Abandoned AU3344299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10951798 1998-04-20
JP10/109517 1998-04-20
PCT/JP1999/002008 WO1999053947A1 (en) 1998-04-20 1999-04-15 Th2-MIGRATION PROMOTERS CONTAINING W/O EMULSIONS

Publications (1)

Publication Number Publication Date
AU3344299A true AU3344299A (en) 1999-11-08

Family

ID=14512280

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33442/99A Abandoned AU3344299A (en) 1998-04-20 1999-04-15 Th2-migration promoters containing w/o emulsions

Country Status (3)

Country Link
JP (1) JP4375773B2 (en)
AU (1) AU3344299A (en)
WO (1) WO1999053947A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7413728B2 (en) * 2003-11-14 2008-08-19 Ucl Biomedica Plc Immune modulator
CA2595063C (en) 2005-01-19 2014-07-08 Dainippon Sumitomo Pharma Co., Ltd. Emulsified composition for dilution and cancer vaccine composition
EP2464341B1 (en) * 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
CN104853614A (en) * 2012-10-24 2015-08-19 卡吉尔公司 Phospholipid-containing emulsifier composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses

Also Published As

Publication number Publication date
WO1999053947A1 (en) 1999-10-28
JP4375773B2 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
EP0882553B8 (en) Knife
AU5489099A (en) Seed-preferred promoters
AU6598798A (en) Resorcinyl-triazines
AU9281698A (en) O/w emulsion compositions
AU6119298A (en) Emulsion composition
AU6804098A (en) Triazinylaminostilbene compounds
AU8456198A (en) Taxol emulsion
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU5272198A (en) EMP-charge-eliminator
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
AU9770498A (en) Regulator
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AUPP042397A0 (en) 5-arylpyrazole compounds
AU7124598A (en) Polymer-platinum compounds
AU6185898A (en) Clavaspirins
AUPP108197A0 (en) Stable emulsions
AU7761998A (en) Korrosionsschutzanstrichstoff
AU3344299A (en) Th2-migration promoters containing w/o emulsions
AU8019998A (en) Fluoromethoximino compounds
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU6613598A (en) Fuel-water emulsions
AU7041098A (en) Pi-complex compounds
AU9753998A (en) Azaboroxine compounds
AU4469997A (en) Heregulin-gamma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase